PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CRON vs. IMCC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CRON and IMCC is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

CRON vs. IMCC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cronos Group Inc. (CRON) and Im Cannabis Corp (IMCC). The values are adjusted to include any dividend payments, if applicable.

-20.00%0.00%20.00%40.00%60.00%80.00%AugustSeptemberOctoberNovemberDecember2025
-17.24%
-1.24%
CRON
IMCC

Key characteristics

Sharpe Ratio

CRON:

-0.07

IMCC:

0.23

Sortino Ratio

CRON:

0.29

IMCC:

1.85

Omega Ratio

CRON:

1.03

IMCC:

1.21

Calmar Ratio

CRON:

-0.04

IMCC:

0.37

Martin Ratio

CRON:

-0.15

IMCC:

0.71

Ulcer Index

CRON:

22.46%

IMCC:

52.12%

Daily Std Dev

CRON:

49.87%

IMCC:

160.99%

Max Drawdown

CRON:

-92.95%

IMCC:

-99.81%

Current Drawdown

CRON:

-91.69%

IMCC:

-99.64%

Fundamentals

Market Cap

CRON:

$756.94M

IMCC:

$7.50M

EPS

CRON:

-$0.12

IMCC:

-$4.03

Total Revenue (TTM)

CRON:

$87.20M

IMCC:

$40.70M

Gross Profit (TTM)

CRON:

$12.24M

IMCC:

$5.77M

EBITDA (TTM)

CRON:

-$41.37M

IMCC:

-$7.81M

Returns By Period

In the year-to-date period, CRON achieves a -2.48% return, which is significantly higher than IMCC's -4.24% return.


CRON

YTD

-2.48%

1M

1.03%

6M

-16.17%

1Y

-1.99%

5Y*

-25.51%

10Y*

N/A

IMCC

YTD

-4.24%

1M

-5.01%

6M

-4.60%

1Y

32.92%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CRON vs. IMCC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRON
The Risk-Adjusted Performance Rank of CRON is 4242
Overall Rank
The Sharpe Ratio Rank of CRON is 4343
Sharpe Ratio Rank
The Sortino Ratio Rank of CRON is 4141
Sortino Ratio Rank
The Omega Ratio Rank of CRON is 3939
Omega Ratio Rank
The Calmar Ratio Rank of CRON is 4545
Calmar Ratio Rank
The Martin Ratio Rank of CRON is 4343
Martin Ratio Rank

IMCC
The Risk-Adjusted Performance Rank of IMCC is 6565
Overall Rank
The Sharpe Ratio Rank of IMCC is 5656
Sharpe Ratio Rank
The Sortino Ratio Rank of IMCC is 7878
Sortino Ratio Rank
The Omega Ratio Rank of IMCC is 7373
Omega Ratio Rank
The Calmar Ratio Rank of IMCC is 6464
Calmar Ratio Rank
The Martin Ratio Rank of IMCC is 5656
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CRON vs. IMCC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Cronos Group Inc. (CRON) and Im Cannabis Corp (IMCC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CRON, currently valued at -0.07, compared to the broader market-2.000.002.004.00-0.070.23
The chart of Sortino ratio for CRON, currently valued at 0.29, compared to the broader market-4.00-2.000.002.004.006.000.291.85
The chart of Omega ratio for CRON, currently valued at 1.03, compared to the broader market0.501.001.502.001.031.21
The chart of Calmar ratio for CRON, currently valued at -0.04, compared to the broader market0.002.004.006.00-0.040.37
The chart of Martin ratio for CRON, currently valued at -0.15, compared to the broader market-10.000.0010.0020.0030.00-0.150.71
CRON
IMCC

The current CRON Sharpe Ratio is -0.07, which is lower than the IMCC Sharpe Ratio of 0.23. The chart below compares the historical Sharpe Ratios of CRON and IMCC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.40-0.200.000.200.400.600.80AugustSeptemberOctoberNovemberDecember2025
-0.07
0.23
CRON
IMCC

Dividends

CRON vs. IMCC - Dividend Comparison

Neither CRON nor IMCC has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

CRON vs. IMCC - Drawdown Comparison

The maximum CRON drawdown since its inception was -92.95%, smaller than the maximum IMCC drawdown of -99.81%. Use the drawdown chart below to compare losses from any high point for CRON and IMCC. For additional features, visit the drawdowns tool.


-100.00%-95.00%-90.00%-85.00%AugustSeptemberOctoberNovemberDecember2025
-87.33%
-99.64%
CRON
IMCC

Volatility

CRON vs. IMCC - Volatility Comparison

The current volatility for Cronos Group Inc. (CRON) is 8.91%, while Im Cannabis Corp (IMCC) has a volatility of 26.18%. This indicates that CRON experiences smaller price fluctuations and is considered to be less risky than IMCC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%60.00%AugustSeptemberOctoberNovemberDecember2025
8.91%
26.18%
CRON
IMCC

Financials

CRON vs. IMCC - Financials Comparison

This section allows you to compare key financial metrics between Cronos Group Inc. and Im Cannabis Corp. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab